Delek Logistics Partners (DKL) is rated Buy due to its attractive 8.33% yield and expected EBITDA growth by 2027, driven by expansion in the Permian Basin. The company recently issued a 9% equity dilution to fund growth projects like Libby, targeting a $75 million EBITDA increase at favorable multiples. By 2026, 80% of DKL's pro forma EBITDA is expected from third-party sources, with strong contributions from Permian assets. Although the valuation is not discounted, the base case price target is $62 per unit, up from the current $53.89, with distribution stability helping offset dilution risks.
Delek Logistics Partners is the subject, with Pluang's Energy sector data providing context. For readers following energy stocks, 31 of 38 US energy stocks rose today. Notable movers include INDO at USD 2.88 (+2.49%), EQNR at USD 43.12 (+2.20%), and CVE at USD 31.61 (+2.20%), as of Sep 28, 2026 18:42 WIB.
Morgan Stanley reaffirmed an "Overweight" rating on Cullen/Frost Bankers, Inc., raising its price target to $201, signaling confidence in the bank's prospects. Major institutional investors like State Street Corp and BlackRock have increased or initi...
AAR Corp. is set to report strong Q1 earnings with analysts expecting EPS of around $1.29 and revenue near $882 million, up significantly from last year. The company benefits from robust organic growth in aviation parts distribution, supporting healt...
Royal Caribbean Cruises Ltd. is expanding into the all-inclusive resort sector by acquiring a 50% stake in Sandals and Beaches Resorts for $3 billion. This strategic move aims to broaden Royal Caribbean's presence in the $2 trillion global vacation m...
CarMax is set to report its Q3 2026 earnings with analysts predicting an EPS of about $0.73 and revenue near $7.09 billion, indicating growth from last year despite a weak auto market. The company has recently cut 145 corporate jobs as part of ongoin...
Micron Technology is poised for significant growth driven by strong AI demand for its memory products like DRAM, NAND, and HBM4. Analysts have set a price target of $1,520, suggesting a 40% upside from its current price of $1,082. Earnings are expect...
